Inspire Medical Systems (INSP) Cash from Financing Activities (2017 - 2026)

Inspire Medical Systems has disclosed Cash from Financing Activities across 10 years of filings, most recently posting -$7.5 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$7.5 million, up 91.47% year-over-year; the trailing twelve-month figure through Mar 2026 was -$103.2 million (up 26.79% YoY), and the FY2025 annual result was -$183.4 million, down 250.14% from the prior year.
• Cash from Financing Activities came in at -$7.5 million for Q1 2026 at Inspire Medical Systems, up from -$48.3 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $224.1 million in Q3 2022 to a low of -$87.8 million in Q1 2025.
• The 5-year median for Cash from Financing Activities is $3.0 million (2022), against an average of $335470.6.
• Across the five-year window, Cash from Financing Activities soared 5732.03% in 2022 and tumbled 11527.08% in 2025, its largest moves.
• Inspire Medical Systems' Cash from Financing Activities stood at $7.3 million in 2022, then sank by 238.77% to -$10.1 million in 2023, then sank by 593.41% to -$70.1 million in 2024, then soared by 31.12% to -$48.3 million in 2025, then jumped by 84.51% to -$7.5 million in 2026.
• The last three Cash from Financing Activities figures came in at -$7.5 million (Q1 2026), -$48.3 million (Q4 2025), and -$51.1 million (Q3 2025), per Business Quant data.